STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] RenovoRx, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

AWM Investment Company, Inc. reports beneficial ownership of 1,870,225 shares of RenovoRx common stock, representing 5.1% of the class. AWM is the investment adviser to three funds that together hold the shares and, as adviser, holds sole voting and dispositive power over the position. The reported holdings break down to 1,064,431 shares held by Special Situations Fund III QP, 296,698 shares held by Special Situations Cayman Fund, and 509,096 shares held by Special Situations Life Sciences Fund.

The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Disclosure shows a >5% aggregated stake managed by AWM with sole voting and investment power, a routine but material ownership filing.

AWM's 5.1% position crosses the reporting threshold and consolidates voting and dispositive authority across three affiliated funds. This filing is informational: it updates the market on ownership concentration rather than announcing transactions, financing, or strategic changes. For investors, the key point is centralized control by an adviser over a modest but reportable stake, which can affect shareholder dynamics if combined with other holders.

TL;DR: AWM holds sole voting and dispositive power for a >5% stake across affiliated funds; filing signals adviser-led control of shares.

The filing clarifies the allocation of voting and investment authority among AWM and its principals. Identification of sole voting and dispositive power is important for governance transparency because it shows who can vote shares on proxy matters. The certification that holdings are in the ordinary course reduces concerns about an immediate control intent, but the consolidated authority is relevant for board-related votes or proxy contests.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP) and Special Situations Life Sciences Fund, L.P. (SSLS). (CAYMAN, SSFQP, and SSLS will hereafter be referred to as the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 1,064,431 shares of Common Stock of the Issuer (the Shares) held by SSFQP, 296,698 shares of Common Stock held by CAYMAN and 509,096 shares of Common Stock held by SSLS


SCHEDULE 13G



AWM Investment Company, Inc.
Signature:Adam Stettner
Name/Title:Executive Vice President
Date:06/30/2025

FAQ

What percentage of RenovoRx (RNXT) does AWM Investment Company, Inc. report owning?

AWM reports beneficial ownership of 1,870,225 shares, representing 5.1% of the class.

Which funds hold the RenovoRx shares reported by AWM?

The shares are held by Special Situations Fund III QP (1,064,431 shares), Special Situations Cayman Fund (296,698 shares), and Special Situations Life Sciences Fund (509,096 shares).

Does AWM have voting control over the reported RenovoRx shares?

Yes. AWM, as investment adviser to the funds, reports sole voting power and sole dispositive power over the reported shares.

Was the position reported as acquired to influence control of RenovoRx?

No. The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Does the filing indicate any group affiliation or joint filing?

No. The filing indicates no shared voting or dispositive power and does not identify any group with shared ownership.
Renovorx Inc

NASDAQ:RNXT

RNXT Rankings

RNXT Latest News

RNXT Latest SEC Filings

RNXT Stock Data

26.85M
33.10M
4.44%
24%
0.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
MOUNTAIN VIEW